Harvard Medical School

25 Shattuck Street, Boston, MA 02115, United States  All United States companies → — Founded 1782
AI Research Lab
Anesthesiology Cardiology critical-care-medicine Dermatology
Clinical Decision Support & Reference Medical Education & Training
N/A (Academic Institution)
Website Claim this company

Products

Harvard Medical School
Harvard Medical School
Clinical Decision Support & Reference
Harvard Medical School offers a CME course on AI in Clinical Medicine, providing physicians with foundational knowledge and practical applications of AI in healthcare.
$1,200 - $2,500

See all 1 product →

About Harvard Medical School

Harvard Medical School (HMS) is a prestigious institution renowned for its contributions to medical education, research, and patient care. Established in 1782, it is the third oldest medical school in the United States and is located in the Longwood Medical Area in Boston, Massachusetts. HMS does not directly own or operate hospitals but collaborates with 15 affiliated clinical institutions and research institutes, including Massachusetts General Hospital and Boston Children’s Hospital, to provide comprehensive medical education and training.

For physicians, HMS offers a dynamic environment for learning and professional development. The school is actively integrating artificial intelligence (AI) into its curriculum, preparing future physicians for a healthcare landscape increasingly influenced by AI. This includes a mandatory introductory course on AI in healthcare for students in the Health Sciences and Technology (HST) track, as well as a PhD program in AI in Medicine. Additionally, HMS provides continuing education courses like “AI in Clinical Medicine” for licensed physicians seeking to enhance their skills in emerging medical technologies. The institution emphasizes a flipped classroom model and collaborative learning, encouraging students to engage in research endeavors with its extensive faculty.

HMS is a hub for groundbreaking research and innovation, with faculty members at the forefront of major medical discoveries. The school’s mission is to alleviate human suffering and improve health and well-being through excellence in teaching, learning, discovery, scholarship, and service. It fosters a diverse and inclusive community dedicated to advancing medicine and science.

Focus Areas

Medical Education Biomedical Research Patient Care Artificial Intelligence in Healthcare Stem Cell Science Cancer Biology Genetics Immunology Clinical Investigation Global Health Delivery Healthcare Quality and Safety Bioethics Medical Informatics.

What Physicians Need to Know

Medical Education
Harvard Medical School (HMS) is a global leader in medical education, attracting top-tier applicants, faculty, and staff. They have a recently revised 'Pathways' curriculum that promotes active learning, critical thinking, and earlier clinical experience. HMS is integrating AI into its curriculum, including a month-long introductory course on AI in healthcare for Health Sciences and Technology (HST) students, and plans for an AI 'tutor bot' by 2025. They also offer a flipped classroom model where AI can provide feedback to faculty on hundreds of student responses daily.
Biomedical Research
HMS is a vibrant hub of research and education, with 12,000 faculty and 1,600 medical and graduate students across its campus and 15 affiliated hospitals. Their scientists are at the forefront of biomedical discovery, deepening understanding of human biology, illuminating disease mechanisms, and contributing to new treatments and diagnostic tools. Recent research highlights include new understandings of Huntington's disease, the role of lithium in Alzheimer's, and promising kidney cancer vaccines. They are also actively using AI to accelerate discoveries in cancer, infectious diseases, genetics, and drug development.
Patient Care
HMS and its affiliated hospitals are dedicated to transforming patient care. AI is already reshaping how healthcare professionals deliver care, manage operations, and prepare future clinicians, improving outcomes, streamlining workflows, and enhancing patient experiences. This includes the use of 'AI scribes' to reduce administrative burden and allow doctors to focus more on patient communication.
Artificial Intelligence in Healthcare
HMS is a leader in integrating AI into healthcare. They offer an 'AI in Clinical Medicine' continuing education course for licensed physicians and a PhD program in Artificial Intelligence in Medicine (AIM). AI is being used as an educational tool, to automate routine tasks for clinicians, and to prepare students for AI's impact on future clinics and laboratories. Their Department of Biomedical Informatics is transforming large biomedical datasets into computational technologies in genomics, machine learning, and AI to advance precision medicine. AIM investigators are actively publishing clinical evaluations of AI algorithms for various applications, including screening for extranodal extension on CT, predicting immunotherapy outcomes in cancer patients, and developing AI for sarcopenia diagnosis.
Stem Cell Science
While specific highlights on 'Stem Cell Science' as a distinct category were not extensively detailed, Harvard Medical School's broader biomedical research efforts, often in collaboration with institutions like the Harvard Stem Cell Institute, contribute to this field. Their research in areas like embryonic development and regeneration of limbs touches upon the fundamental understanding of cell biology.
Cancer Biology
HMS has made significant contributions to cancer research, with 56% of all new cancer drugs and cell therapies approved by the FDA since 2020 originating from HMS and its affiliated hospitals. Researchers are focused on understanding how tumors arise, evolve, evade detection, and how to render them vulnerable. They are developing new immunotherapies, such as checkpoint inhibitors and CAR T-cell therapy. AI is also being used to optimize cancer diagnosis, forecast treatment response, and predict survival.
Genetics
Harvard researchers are working to understand how genes influence lives, from human genetics and cancer biology to synthetic biology and computational genetics. Key achievements include developing the first direct genomic sequencing method, initiating the Human Genome Project, and contributing to the world's first approved medicine based on CRISPR/Cas9 gene-editing technology. They are also using AI to distinguish benign from disease-causing gene variants.
Immunology
The HMS Department of Immunology is a highly collaborative group of scientists working to understand immunity and immunobiology, from basic science to translational applications in human biology and disease prevention and treatment. Research areas include autoimmunity, infectious diseases, transplantation immunology, and cancer immunology. Discoveries made at Harvard have contributed to therapies, treatments, and cures for autoimmune and allergic diseases, cancers, and viral infections.
Clinical Investigation
The Master of Medical Sciences in Clinical Investigation program at HMS provides training in the methods and conduct of clinical discovery for future leaders. This program emphasizes practical skills, critical thinking, and a mentored research experience in a Harvard-affiliated laboratory. Students learn ethical conduct, research question crafting, hypothesis testing, study implementation, data analysis, and results communication.
Global Health Delivery
The Harvard Medical School Master of Medical Sciences in Global Health Delivery program offers education in bio-social research, program design, and management. The Center for Global Health Delivery focuses on research, medical education, and training to improve healthcare delivery systems and patient outcomes in various regions. They also have the Global Health Delivery Project, a collaborative initiative focused on systematizing the study of global health delivery and disseminating knowledge through case studies and professional virtual communities.
Healthcare Quality and Safety
HMS offers a Master of Science in Healthcare Quality and Safety program that equips clinicians and administrators with operational skills and leadership vision for quality improvement and safety initiatives. The curriculum covers operational quality and safety, informatics, leadership and change management, quantitative approaches, and risk assessment and communication. The program emphasizes data-driven solutions and fostering a culture of continuous improvement.
Bioethics
The Harvard Medical School Center for Bioethics ensures that values and ethics are integral to medical training, research, and professional education. They offer a Master of Science in Bioethics and various fellowship programs, focusing on ethical issues in clinical care, research, and public policy. Research areas include end-of-life care, organ transplantation, resource allocation, informed consent, and neuroethics.
Medical Informatics
The HMS Department of Biomedical Informatics (DBMI) is dedicated to integrating, interpreting, and acting upon complex biomedical data. They offer a Master of Science in Biomedical Informatics and a PhD in Biomedical Informatics with tracks in Bioinformatics and Integrative Genomics (BIG) and Artificial Intelligence in Medicine (AIM). DBMI transforms large datasets into computational technologies in genomics, machine learning, and AI to advance precision medicine. They are also involved in creating patient-centered information commons to bring together diverse patient data for research and individual care.
Physician Tip

For physicians looking to engage with Harvard Medical School, consider their extensive continuing education courses, particularly in emerging fields like AI in Clinical Medicine. Their Master of Medical Sciences programs in Clinical Investigation, Global Health Delivery, and Healthcare Quality and Safety offer rigorous training and mentored research opportunities for career advancement. For those interested in research, HMS provides a collaborative environment with world-class resources and a vast network of affiliated hospitals. Leveraging their expertise in AI and biomedical informatics can provide valuable tools for improving patient care and streamlining workflows. Additionally, engaging with the Center for Bioethics can offer crucial insights into the ethical dimensions of new medical discoveries and practices.

Harvard Medical School's emphasis on interdisciplinary collaboration is a key aspect of its operations. They actively integrate research across Harvard, HMS, and affiliated hospitals. Their Global Health Delivery Project is a joint initiative with Harvard Business School, Harvard School of Public Health, and Brigham and Women's Hospital. The Department of Biomedical Informatics collaborates with HMS Quad-based researchers and has established large collaborations with researchers at affiliated hospitals and the Harvard University Faculty of Arts and Sciences. They also partner with generative AI and digital tool providers to integrate the latest evidence into clinical decision-making.

Products by Harvard Medical School

1 product in the directory

Harvard Medical School
Harvard Medical School
Clinical Decision Support & Reference
Harvard Medical School offers a CME course on AI in Clinical Medicine, providing physicians with foundational knowledge and practical applications of AI in healthcare.
$1,200 - $2,500

Videos

News, demos, and interviews about Harvard Medical School.

Loading videos...

Videos load interactively. If none appear, search YouTube for Harvard Medical School →

View all on YouTube

Press & Coverage

Harvard Medical School
New Gene-Editing Method, 'Prime Assembly,' Corrects Multiple Mutations at Once
Harvard Medical School researchers have developed 'prime assembly,' a novel gene-editing method that can stitch long DNA fragments into precise locations within living cells, potentially leading to universal gene therapies for diseases with many mutations.
2026-09
Harvard Medical School
Researchers Create Molecular Map of Hypertrophic Cardiomyopathy
An international team, including Harvard Medical School researchers, has created a detailed molecular map of hypertrophic cardiomyopathy (HCM), providing insights into the disease's drivers and potential new treatments.
2026-09
GlobeNewswire
BDu00b2 Awards over $13 Million in Grants to Understand the Mechanisms of Mood State Switching in Bipolar Disorder and Announces New Funding Available
BDu00b2 has awarded over $13 million in grants to research teams, including one from Harvard Medical School, to study the biological mechanisms of mood changes in bipolar disorder.
2026-09
BioSpace
First-Ever Standardized U.S. Treatment Recommendations Issued for Adults with Severe Alopecia Areata; Sun Pharma Welcomes Milestone
New standardized U.S. treatment recommendations for severe alopecia areata, with contributions from a Harvard Medical School associate professor, establish oral JAK inhibitors as a primary therapy.
2026-09
MIT News
New AI technique could make minimally invasive surgeries safer and more precise
A new AI technique, co-developed by researchers including those from Harvard Medical School, can accurately and rapidly match X-rays with 3D medical scans, potentially making minimally invasive surgeries safer.
2026-09
AI Weekly
AMIE team pushes prospective trials for medical chatbots | AI Weekly
A team from Google Research, Google DeepMind, Harvard Medical School, and Stanford argues in Nature Medicine that trust in clinical AI must come from prospective studies in real clinics, not just benchmarks.
2026-09
GlobeNewswire
U.S. FDA Approves Revolution Medicines' RASONQUEu2122 (daraxonrasib), the First Broad RAS-Targeted Medicine in Metastatic Pancreatic Cancer
The FDA has approved RASONQUE (daraxonrasib), the first broad RAS-targeted medicine for metastatic pancreatic cancer, with a Harvard Medical School professor serving as a principal investigator for the supporting trial.
2026-08
Insilico Medicine
Insilico Medicine Opens AI Longevity Discovery Toolkit to Researchers Worldwide in Cell Cover Study
Insilico Medicine, in collaboration with Harvard Medical School and others, published a study in Cell introducing an open AI toolkit to accelerate research and therapeutic development in aging and longevity.
2026-09

Frequently Asked Questions

Harvard Medical School is actively integrating AI into its curriculum through dedicated courses and research initiatives focused on machine learning applications in diagnostics, prognostics, and personalized medicine. The institution is also fostering collaborations with tech companies and hospitals to develop and validate AI tools for clinical use and to train the next generation of physician-scientists in AI.
Harvard Medical School has robust programs in Stem Cell Science, focusing on regenerative medicine, disease modeling, and therapeutic development, often through its Stem Cell and Regenerative Biology Department. In Cancer Biology, research spans from fundamental mechanisms of carcinogenesis to novel therapeutic strategies, including immunotherapy and targeted therapies, with significant work conducted at affiliated hospitals and research centers.
Harvard Medical School supports clinical investigation through its extensive network of affiliated hospitals, providing a rich environment for patient-oriented research and clinical trials. The institution emphasizes translational research, aiming to bridge basic science discoveries with clinical applications to improve patient outcomes and advance healthcare practices.
Harvard Medical School is deeply involved in Global Health Delivery through programs that focus on strengthening health systems, training healthcare professionals, and conducting research on prevalent global health challenges. The institution works to address healthcare disparities by partnering with organizations in low-resource settings and developing sustainable solutions for health equity.
Harvard Medical School offers various programs and resources in Healthcare Quality and Safety, including master's programs, fellowships, and continuing medical education courses designed to equip professionals with the skills to improve patient outcomes and reduce medical errors. In Bioethics, the institution provides robust educational and research opportunities, addressing complex ethical dilemmas in medicine, research, and public health.
Harvard Medical School utilizes Medical Informatics to optimize data management, analysis, and interpretation across its educational, research, and clinical enterprises. This includes developing and implementing electronic health record systems, leveraging big data for research insights, and integrating informatics tools into medical training to prepare future physicians for data-driven healthcare.
In Genetics, Harvard Medical School's research spans from fundamental genetic mechanisms to the genetic basis of human diseases, including genomics, epigenetics, and gene therapy. Immunology research focuses on understanding immune system function, autoimmune diseases, infectious diseases, and cancer immunology, aiming to develop new diagnostic and therapeutic strategies.

Related Companies

Google
1600 Amphitheatre Parkway, Mountain View, CA 94043

Google, a global technology leader, is making significant strides in the healthcare sector through its advanced artificial intelligence (AI) and cloud computing capabilities. For physicians, Google’s initiatives aim to enhance patient care, streamline clinical workflows, and accelerate medical research. This includes developing AI models for improved diagnostic accuracy, such as interpreting medical images and analyzing […]
A2
A2z Radiology Ai
Boston, MA, USA

A2z Radiology AI is a Boston-based medical imaging AI company that develops software for comprehensive CT interpretation, initially focusing on abdomen-pelvis CT scans. The company’s primary goal is to enhance diagnostic accuracy and efficiency in medical imaging for healthcare providers by leveraging artificial intelligence. Their flagship product, a2z-Unified-Triage, is FDA-cleared radiological computer-aided triage and notification […]
Op
OpenAI
San Francisco, California, U.S. (specifically 1455 Third Street, San Francisco, California 94158, United States or 3180 18th Street, San Francisco, California 94110, United States)

OpenAI is an American artificial intelligence (AI) company that conducts research and develops advanced AI models. While widely known for its generative AI models like ChatGPT and DALL-E, OpenAI has significantly expanded its focus into the healthcare sector. The company’s mission is to ensure that artificial general intelligence (AGI) benefits all of humanity, and this […]
Pe
Perimeter Medical Imaging AI
Toronto, Canada and Dallas, Texas, USA

Perimeter Medical Imaging AI is a medical technology company dedicated to transforming cancer surgery through the use of ultra-high-resolution, real-time, advanced imaging tools. The company’s mission is to address significant unmet medical needs in cancer surgery, particularly concerning positive margins and the resulting need for re-excisions. Their proprietary technology, including the S-Series Optical Coherence Tomography […]
Veeva Systems
Pleasanton, California, U.S.

Veeva Systems is a global leader in cloud-based software solutions specifically designed for the life sciences industry, including pharmaceutical and biotech companies. The company’s offerings are crucial for managing various aspects of drug development, pharmaceutical manufacturing, and commercial operations. Their platforms help clients navigate complex regulatory requirements, improve operational efficiency, and accelerate the delivery of […]
University at Buffalo (UB)
Buffalo, New York, USA

The University at Buffalo (UB) is a prominent public research university and a flagship institution of the State University of New York (SUNY) system. While UB itself is a broad academic institution, the provided URL (halsted.compbio.buffalo.edu) points to a specific area within UB focused on computational biology. This division is actively engaged in healthcare AI […]
Suggest an Edit → | Report an issue
AI Tool Finder
AI-powered search. Results may not be comprehensive.